Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bing-Liang Lin

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
World Journal of Clinical Cases|July 26, 2021
Rapid diagnosis of disseminated <i>Mycobacterium mucogenicum</i> infection in formalin-fixed, paraffin-embedded specimen using next-generation sequencing: A case reportJing Liu, Zi-Ying Lei, Yi-Hua Pang, et al.
Liver Research|February 17, 2025
Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogueLi-Li Wu, Xiao-Yan Li, Kai Deng, et al.
Stem Cell Research & Therapy|February 26, 2026
Mesenchymal stem cells-derived TGF-β1 promotes polarization of M2 macrophages in mice with acute-on-chronic liver failure via FOSL1/MERTK axisJun-Feng Chen, Zhi-Hui Li, Jing Zhang, et al.
Immunopharmacology and Immunotoxicology|March 26, 2026
Thymosin α1 improves the outcomes of patients with hepatitis B virus-related acute-on-chronic liver failure by restoring immune balanceZhi-Hui Li, Li-Li Wu, Yuan-Qiang Zhu, et al.
Gut Microbes|May 19, 2021
Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failureKe Wang, Zhao Zhang, Zhi-Shuo Mo, et al.
Molecular Cancer|May 27, 2024
CircPIAS1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis via the miR-455-3p/NUPR1/FTH1 axisXiao-Yu Zhang, Shan-Shan Li, Yu-Rong Gu, et al.
Hepatology International|May 26, 2022
Safety and efficacy of Thymosin α1 in the treatment of hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trialJun-Feng Chen, Shu-Ru Chen, Zi-Ying Lei, et al.
Stem Cells (Dayton, Ohio)|September 2, 2023
Mesenchymal Stem Cells Promote Polarization of M2 Macrophages in Mice with Acute-On-Chronic Liver Failure via Mertk/JAK1/STAT6 SignalingZhi-Hui Li, Jun-Feng Chen, Jing Zhang, et al.
Travel Medicine and Infectious Disease|April 13, 2020
A cross-sectional comparison of epidemiological and clinical features of patients with coronavirus disease (COVID-19) in Wuhan and outside Wuhan, ChinaZiying Lei, Huijuan Cao, Yusheng Jie, et al.
Frontiers in Medicine|July 5, 2021
Derivation and Validation of a Nomogram for Predicting 90-Day Survival in Patients With HBV-Related Acute-on-Chronic Liver FailureJun-Feng Chen, Wei-Zhen Weng, Miao Huang, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
World Journal of Clinical Cases|July 26, 2021
Rapid diagnosis of disseminated <i>Mycobacterium mucogenicum</i> infection in formalin-fixed, paraffin-embedded specimen using next-generation sequencing: A case reportJing Liu, Zi-Ying Lei, Yi-Hua Pang, et al.
Liver Research|February 17, 2025
Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogueLi-Li Wu, Xiao-Yan Li, Kai Deng, et al.
Stem Cell Research & Therapy|February 26, 2026
Mesenchymal stem cells-derived TGF-β1 promotes polarization of M2 macrophages in mice with acute-on-chronic liver failure via FOSL1/MERTK axisJun-Feng Chen, Zhi-Hui Li, Jing Zhang, et al.
Immunopharmacology and Immunotoxicology|March 26, 2026
Thymosin α1 improves the outcomes of patients with hepatitis B virus-related acute-on-chronic liver failure by restoring immune balanceZhi-Hui Li, Li-Li Wu, Yuan-Qiang Zhu, et al.
Gut Microbes|May 19, 2021
Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failureKe Wang, Zhao Zhang, Zhi-Shuo Mo, et al.
Molecular Cancer|May 27, 2024
CircPIAS1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis via the miR-455-3p/NUPR1/FTH1 axisXiao-Yu Zhang, Shan-Shan Li, Yu-Rong Gu, et al.
Hepatology International|May 26, 2022
Safety and efficacy of Thymosin α1 in the treatment of hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trialJun-Feng Chen, Shu-Ru Chen, Zi-Ying Lei, et al.
Stem Cells (Dayton, Ohio)|September 2, 2023
Mesenchymal Stem Cells Promote Polarization of M2 Macrophages in Mice with Acute-On-Chronic Liver Failure via Mertk/JAK1/STAT6 SignalingZhi-Hui Li, Jun-Feng Chen, Jing Zhang, et al.
Travel Medicine and Infectious Disease|April 13, 2020
A cross-sectional comparison of epidemiological and clinical features of patients with coronavirus disease (COVID-19) in Wuhan and outside Wuhan, ChinaZiying Lei, Huijuan Cao, Yusheng Jie, et al.
Frontiers in Medicine|July 5, 2021
Derivation and Validation of a Nomogram for Predicting 90-Day Survival in Patients With HBV-Related Acute-on-Chronic Liver FailureJun-Feng Chen, Wei-Zhen Weng, Miao Huang, et al.
Pageof 5